KLA CORPORATION
Last · NasdaqGS$174.46-4.35 (-2.43%)live · yahoo · 1h ago
Vol 13.48M ≈ 2.35B
MA10MA20MA50
Market cap$227.67B1.31B sh
P/E · TTM49.0fwd 25.9 · eps 3.56
Beta—vs S&P 500
Div yield0.45%annual · TTM
52w range
$107.20$307.37
Volume13.5Msession
Issuer
Legal nameKLA CORPORATION
HQUnited States (US)
ListingUS KLAC
ISINUS4824801009
SectorHealthcare
IndustryHealthcare Products
SIC3827
CurrencyUSD
Entity registrysec:0000319201
CIK0000319201
Websitewww.kla.com
Employees15,100
AddressKLA Corp. Three Technology Drive 95035-7916, Milpitas +408 875 3000
| Revenue | $13.1B |
|---|---|
| Operating income | $5.4B |
| Net income | $4.7B |
| Free cash flow | $4.0B |
| Operating margin | 41.1% |
| Net margin | 35.7% |
| Return on equity | 80.1% |
| Period | TTM 2026-03-31 |
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-08-06
From latest 10-K · 2026-08-06
- Ai Hpc Demand
- Process Control Intensity
- China Export Controls
- Customer Concentration
- Services Revenue
- Advanced Packaging
- Debt Commitments
Red flags
- China accounted for $4.05 billion, or 29.8%, of fiscal 2026 revenue; export-control restrictions already offset domestic legacy-node investment, creating material geopolitical and regulatory exposure.
- Taiwan Semiconductor Manufacturing Company Limited accounted for more than 10% of total revenue, while KLA states that its customer base is highly concentrated and configured orders may create significant non-recoverable costs if delayed or canceled.
- KLA had $5.89 billion of long-term debt at June 30, 2026, including $2.25 billion due in 2049-2062, increasing sensitivity to financing and interest-rate conditions.
- Significant purchase commitments totaled approximately $5.97 billion, a majority due within 12 months, creating inventory and cancellation-risk exposure if semiconductor spending weakens.
Upcoming earnings
WED.28OCT
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
$1.18
Est. revenue
4.0B
Earnings transcripts
Documents
FormReporting forFiledFlags
Showing 5 of 85 filings